Elosity

Elosity is the next-generation Randomization and Trial Supply Management (RTSM) platform from Endpoint Clinical, purpose-built to simplify complex clinical trial operations and accelerate study launches. Building on more than 15 years of experience with the PULSE platform, Elosity represents the fifth generation of RTSM technology, delivering unmatched speed, flexibility, and reliability for clinical trials of all complexities. It is designed for sponsors and clinical operations teams who need an agile, scalable solution that adapts to evolving study designs without constraining their workflows.

Elosity combines modern cloud architecture with intuitive design and predictive automation to reduce errors, streamline trial management, and support global study operations. Whether managing a straightforward study or a highly complex multi-arm program, Elosity provides the tools and infrastructure needed to meet critical trial endpoints efficiently.

Core Benefits

• Speed to Market: Elosity enables new study builds in as little as 2–4 weeks, supporting faster study launches even when a finished protocol is not yet available.
• Reduced Risk: Predictive automation and seamless resupply management work together to eliminate errors that could jeopardize trial integrity.
• Future-Proofing: Built on modern cloud architecture, Elosity is designed to adapt to evolving study designs and changing industry standards over time.
• Global Support: Users have access to dedicated Endpoint Clinical employees with expertise in worldwide study operations, ensuring consistent support across geographies.

Key Platform Capabilities

• Multi-Tenant Platform: Elosity operates as a scalable multi-tenant environment, supporting multiple studies and programs efficiently within a shared infrastructure.
• Simplified Amendments: The platform is designed to make protocol amendments straightforward, reducing the time and complexity typically associated with mid-study changes.
• Advanced Data Access: Elosity provides robust data access capabilities, enabling teams to retrieve and act on trial data with greater speed and precision.
• Cutting-Edge Automation: Automation is embedded throughout the platform to minimize manual intervention, reduce human error, and streamline routine trial management tasks.
• System-Generated Tools: The platform includes system-generated tools that support operational efficiency and reduce the burden on study teams.
• Seamless Drug Pooling: Elosity supports advanced drug pooling functionality, enabling flexible and efficient management of investigational product supply across sites and regions.

Elosity is offered by Endpoint Clinical, headquartered in Raleigh, NC, and is available alongside the company's established PULSE RTSM platform. Organizations interested in modernizing their trial supply management and randomization processes can request a demo directly through Endpoint Clinical.